Pluripotent stem cell-derived natural killer cells for cancer therapy.
Human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) provide an accessible, genetically tractable, and homogenous starting cell population to efficiently study human blood cell development. These cell populations provide platforms to develop new cell-based therapies to treat both malignant and nonmalignant hematological diseases. Our group previously demonstrated the ability of hESC-derived hematopoietic precursors to produce functional natural killer (NK) cells as well as an explanation of the underlying mechanism responsible for the inefficient development of T and B cells from hESCs. hESCs and iPSCs, which can be engineered reliably in vitro, provide an important new model system to study human lymphocyte development and produce enhanced cell-based therapies with the potential to serve as a "universal" source of antitumor lymphocytes. This review will focus on the application of hESC-derived NK cells with currently used and novel therapeutics for clinical trials, barriers to translation, and future applications through genetic engineering approaches.
Knorr
David A
DA
Department of Medicine and Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, USA.
Kaufman
Dan S
DS
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D002292:Carcinoma, Renal Cell / Q000601:surgery; D002454:Cell Differentiation; D002986:Clinical Trials as Topic; D019337:Hematologic Neoplasms / Q000601:surgery*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods; D007680:Kidney Neoplasms / Q000601:surgery; D007694:Killer Cells, Natural / Q000637:transplantation*; D008214:Lymphocytes / Q000166:cytology / Q000502:physiology; D008545:Melanoma / Q000601:surgery; D051379:Mice; D023421:Models, Animal; D009369:Neoplasms / Q000601:surgery*; D039904:Pluripotent Stem Cells / Q000166:cytology / Q000637:transplantation*; D013119:Spinal Cord Injuries / Q000601:surgery; D033581:Stem Cell Transplantation / Q000379:methods*; D013601:T-Lymphocytes / Q000276:immunology
Nature. 2009 Jul 2;460(7251):53-9
19483674
Hum Gene Ther. 2009 Nov;20(11):1229-39
19702437
Cell. 2007 Nov 30;131(5):861-72
18035408
Stem Cells. 2010 Jan;28(1):64-74
19904830
Cell. 2008 Sep 5;134(5):877-86
18691744
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6106-15
17062687
Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5
2679456
Stem Cells. 2007 Sep;25(9):2206-14
17556598
Blood. 2010 Apr 1;115(13):2592-600
20110425
Immunol Rev. 2006 Dec;214:143-54
17100882
N Engl J Med. 1988 Dec 22;319(25):1676-80
3264384
Nat Immunol. 2008 Jun;9(6):575-80
18490903
Cell Stem Cell. 2010 May 7;6(5):407-11
20452313
J Neurosci. 2005 May 11;25(19):4694-705
15888645
Blood. 2005 Mar 15;105(6):2594-600
15536148
Nature. 2008 Jan 10;451(7175):141-6
18157115
Nat Rev Cancer. 2003 Sep;3(9):666-75
12951585
Science. 1998 Nov 6;282(5391):1145-7
9804556
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11742-7
16844782
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16254-9
18838682
Blood. 2003 Aug 1;102(3):814-9
12689936
Science. 2009 May 8;324(5928):797-801
19325077
Semin Hematol. 1999 Oct;36(4 Suppl 7):95-103
10595758
Blood. 2009 Jun 11;113(24):6094-101
19365083
J Immunol. 1992 Sep 15;149(6):1876-80
1387664
Nature. 2007 Jul 19;448(7151):318-24
17554336
Immunol Rev. 2006 Dec;214:229-38
17100888
Nat Rev Cancer. 2008 Apr;8(4):299-308
18354418
J Immunol. 2004 Mar 1;172(5):2731-8
14978070
Stem Cells. 2009 Nov;27(11):2675-85
19711457
J Exp Med. 2005 May 16;201(10):1603-14
15883170
J Cell Physiol. 2009 Nov;221(2):367-77
19562687
J Virol. 2009 Nov;83(21):11188-95
19692460
Mol Ther. 2010 Apr;18(4):843-51
20179677
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10716-21
11535826
Blood. 2008 Aug 1;112(3):461-9
18650461
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3360-5
19211796
Adv Immunol. 2009;101:27-79
19231592
J Exp Med. 2005 Mar 7;201(5):805-16
15738052
Blood. 2005 Sep 1;106(5):1601-3
15914555
Science. 2002 Mar 15;295(5562):2097-100
11896281
J Immunol. 2005 Oct 15;175(8):5095-103
16210613
J Immunother. 2008 Oct;31(8):742-51
18779745
Blood. 2005 Jan 15;105(2):617-26
15374881
Nat Rev Immunol. 2005 Dec;5(12):928-40
16322746
Nat Rev Immunol. 2005 Nov;5(11):835-43
16239902
Blood. 2005 Feb 15;105(4):1431-9
15494433
Immunity. 2008 Dec 19;29(6):835-8
19100694
J Clin Invest. 2009 Sep;119(9):2818-29
19726877
Transplantation. 2004 Oct 15;78(7):1081-5
15480179
Nat Rev Immunol. 2007 May;7(5):329-39
17438573
Nat Protoc. 2010 Apr;5(4):811-20
20360773
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15768-73
19720998
Cell Stem Cell. 2008 May 8;2(5):422-33
18462693
Blood. 2009 Dec 24;114(27):5473-80
19797525
Blood. 2010 Feb 18;115(7):1354-63
20008788
Curr Opin Immunol. 2003 Jun;15(3):308-14
12787756
Exp Hematol. 2004 Oct;32(10):1000-9
15504555
Blood. 2010 May 20;115(20):4039-42
20233975
Blood. 2009 Oct 22;114(17):3513-23
19652198
Nat Rev Immunol. 2010 May;10(5):317-27
20414205
Cell Stem Cell. 2008 Jul 3;3(1):85-98
18593561
Nat Med. 2010 May;16(5):565-70, 1p following 570
20400962
Cell Stem Cell. 2009 Feb 6;4(2):141-54
19200803
Immunol Rev. 2008 Aug;224:85-97
18759922
Clin Cancer Res. 2007 Apr 1;13(7):2100-8
17404092
Blood. 2008 Oct 1;112(7):2730-7
18621931
Stem Cells. 2009 Mar;27(3):559-67
19259936
Mol Ther. 2010 Apr;18(4):666-8
20357779
Blood. 2005 Apr 15;105(8):3051-7
15632206
Stem Cells. 2007 Nov;25(11):2919-27
17673526
Blood. 2006 Mar 1;107(5):2180-3
16278307
Mol Ther. 2003 Feb;7(2):281-7
12597917
Stem Cells. 2006 May;24(5):1370-80
16456127
J Clin Invest. 2001 Jan;107(2):199-206
11160136
J Immunol. 2009 Jun 1;182(11):6879-88
19454684
Blood. 2010 Mar 25;115(12):2553-4
20339107
Science. 2007 Dec 21;318(5858):1917-20
18029452
Nature. 2009 Sep 3;461(7260):86-90
19672241
Ann N Y Acad Sci. 2009 Sep;1176:219-27
19796250